mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |